Articles by James Paton | Fortune

Skip to Content

SIGN IN

Health
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
By
James Paton
and
Bloomberg
July 31, 2020
International
The earliest coronavirus vaccines may not protect you from getting infected
By
John Lauerman,
James Paton,
and others
June 15, 2020
International
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By
James Paton,
Riley Griffin,
and others
May 26, 2020
Health
Sanofi and GlaxoSmithKline are teaming up to develop a coronavirus vaccine
By
James Paton,
Suzi Ring,
and others
April 14, 2020
Health
A coronavirus vaccine in 18 months? Medical experts say it’s not that simple
By
James Paton
and
Bloomberg
March 31, 2020
International
Why Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs
By
James Paton
and
Bloomberg
December 10, 2019
Health
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
By
Riley Griffin,
James Paton,
and others
December 9, 2019
International
Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value
By
James Paton
and
Bloomberg
December 9, 2019
International
Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By
James Paton
and
Bloomberg
November 25, 2019

1 - 9 of 9 results

1 - 9 of 9 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.